Lifecore Biomedical, Inc. (LFCR) NASDAQ
5.45
+0.6(+12.37%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.45
+0.6(+12.37%)
Currency In USD
| Market Cap | 305.96M |
| Enterprise Value | 431.09M |
| P/E Ratio | -5.99 |
| PEG Ratio | -0.16 |
| Price/Sales Ratio | 1.51 |
| Price/Book Ratio | 9.83 |
| Enterprise/Revenue | 2.47 |
| Enterprise/EBITDA | 122.4 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.25 |
| Operating Margin | -0 |
| Return On Assets | -0.15 |
| Return On Equity | -1.76 |
| Revenue | 128.87M |
| Revenue/Share | 3.61 |
| Gross Profit | 40.3M |
| EBITDA | -8.81M |
| Net Income | -38.72M |
| Diluted EPS | -1.27 |
| Total Cash | 20.8M |
| Total Cash/Share | 0.55 |
| Total Debt | 150.14M |
| Total Debt/Equity | 7.23 |
| Current Ratio | 3.79 |
| Book Value Per Share | 0.55 |
| 52-Week Change | -20.67 |
| 52-Week High | 8.98 |
| 52-Week Low | 3.63 |
| Moving Average 50 Days | 4.69 |
| Moving Average 200 Days | 6.71 |
| Average Volume | 342,304 |
| Shares Outstanding | 37.51M |
| % Held by Institutions | 67.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |